期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 124, 期 1, 页码 79-81出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI73906
关键词
-
资金
- NHLBI NIH HHS [R01 HL062846, R01 HL107319, HL107319, HL062846] Funding Source: Medline
Loeys-Dietz syndrome (LDS) is a connective tissue disorder that is characterized by skeletal abnormalities, craniofacial malformations, and a high predisposition for aortic aneurysm. In this issue of the JCI, Gallo et al. developed transgenic mouse strains harboring missense mutations in the genes encoding type I or II TGF-beta receptors. These mice exhibited several LDS-associated phenotypes. Despite being functionally defective, the mutated receptors enhanced TGF-beta signaling in vivo, inferred by detection of increased levels of phosphorylated Smad2. Aortic aneurysms in these LDS mice were ablated by treatment with the Ang II type 1 (AT1) receptor antagonist losartan. The results from this study will foster further interest into the potential therapeutic implications of AT1 receptor antagonists.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据